NuVasive, Inc. (NASDAQ:NUVA) shares moved up 3.44% in last trading session and ended the day at $48.06. NUVA Gross Margin is 76.00% and its has a return on assets of 5.20%. NuVasive, Inc. (NASDAQ:NUVA) quarterly performance is -10.03%.
NuVasive, Inc. (NASDAQ:NUVA)‘s stock had its “outperform” rating restated by stock analysts at Leerink Swann in a note issued to investors on Thursday, Market Beat Ratings reports.
On 29 March, Barrick Gold Corporation (NYSE:ABX) shares advanced 3.23% and was closed at $14.05. ABX EPS growth in last 5 year was -22.00%. Barrick Gold Corporation (NYSE:ABX) year to date (YTD) performance is 90.66%.
On 25 March, Barrick Gold Corporation (NYSE:ABX) awarded Executive Chairman John Thornton $3.08 million in compensation for 2015, down 76 percent from the year earlier, after the world’s largest gold producer said it had fixed the way it pays executives. Bloomberg Intelligence’s Kenneth Hoffman gives his take. (Source: Bloomberg)
Comcast Corporation (NASDAQ:CMCSA) shares advanced 1.10% in last trading session and ended the day at $60.75. CMCSA Gross Margin is 69.70% and its has a return on assets of 5.10%. Comcast Corporation (NASDAQ:CMCSA) quarterly performance is 6.49%.
On 15 March, Comcast Corporation (NASDAQ:CMCSA) said the service being trialed in Atlanta, which pairs a 1-Gig downstream with an upstream that maxes out at 35 Mbps, is being trialed under two pricing options – a promotional contract price of $70 per month for 36 months and unlimited data, and a no-contract price that runs $139.95 per month.
Cisco Systems, Inc. (NASDAQ:CSCO) caters to the Technology space. It has a net profit margin of 20.80% and weekly performance is -0.32%. On the last day of trading company shares ended up at $28.10. Cisco Systems, Inc. (NASDAQ:CSCO) distance from 50-day simple moving average (SMA50) is 2.44%.
On 25 March, Cisco Systems, Inc. (NASDAQ:CSCO) completed its $1.4 billion acquisition of Jasper Technologies, bringing the fast-growing smaller company into Cisco’s new Internet of Things (IoT) Cloud Business unit.
Versartis, Inc. (NASDAQ:VSAR) caters to the Healthcare space. Its weekly performance is 8.01%. On the last day of trading company shares ended up at $7.55. Versartis, Inc. (NASDAQ:VSAR) distance from 50-day simple moving average (SMA50) is -9.00%.
Versartis, Inc. (NASDAQ:VSAR) announced that detailed two-year, safety, efficacy and adherence data from its ongoing Extension Study of somavaratan in children with GHD will be featured in two late-breaker presentations at the Endocrine Society’s 98th Annual Meeting & Expo (ENDO 2016), to be held April 1-4, 2016, in Boston, MA. The Extension Study is a long-term safety study that was initiated in March 2014 as patients completed the Phase 1b/2a clinical trial evaluating somavaratan therapy in treatment-naive, pre-pubertal GHD children.
Leave a Reply